Stelic Institute & Co..

tin4.jpg

Dec 07, 2015.

  • Stelic announced a new peer-reviewed publication describing the mechanism of CHST15 siRNA in pancreatic cancer, entitled “Inhibition of cell proliferation and growth of pancreatic cancer by silencing of carbohydrate sulfotransferase 15 in vitro and in a xenograft model.” In PLoS One.
  • Link: http://www.ncbi.nlm.nih.gov/pubmed/26642349

Oct 28, 2015.

  • Stelic announced that Dr. Nishimura at Tokyo Metropolitan Geriatric Hospital presented interim results at United European Gastroenterology Week (UEGW) Barcelona, Spain entitled “EUS-guided intratumoral injection of CHST15 dsRNA for unresectable pancreatic cancer: An investigator-initiated trial” and awarded the poster of excellence.

June 2, 2015

  • Stelic announced that Dr. Nishimura at Tokyo Metropolitan Geriatric Hospital presented interim results at American Society of Clinical Oncology (ASCO) Chicago, US, entitled “A translational study to investigate the role of carbohydrate sulfotransferase 15 for pancreatic cancer biology from in vitro to first-in-human clinical research.”

May 23, 2015.

  • Stelic announced the patent related to STNM01 was granted, entitled “Method of fixing and expressing physiological active substance” in Japan.

May 19. 2015

  • Stelic announced that Dr. Nishimura at Tokyo Metropolitan Geriatric Hospital presented interim results at Digestive Disease Week (DDW) Washington DC, US, entitled “EUS-guided intratumoral injection of CHST15 dsRNA for unresectable pancreatic cancer: An investigator-initiated trial”.

Mar 14, 2015.

  • Stelic announced a new peer-reviewed publication describing the mechanism of CHST15 siRNA in rat model of cardiac fibrosis, entitled “Small interfering RNA therapy against carbohydrate sulfotransferese 15 inhibits cardiac remodeling in rats with dilated cardiomyopathy” In Cell Signaling.
  • Link: http://www.ncbi.nlm.nih.gov/pubmed/25778904

Feb 21, 2015.

  • Stelic announced the patent related to STNM01 was granted, entitled “Sugar chain-related gene and use thereof” in Japan.

ページの先頭へ